Micobes and Social Equity speaker series 2024:
“The human microbiome and cancer risk: Opportunities
for prospective studies.”, presented by Dr. Emily Vogtmann.
May 31, 2024 12:00 PM Eastern Daylight Time.
Dr. Emily Vogtmann is an
Earl Stadtman Investigator in the Metabolic Epidemiology Branch of the Division
of Cancer Epidemiology & Genetics in the National Cancer Institute. She received her B.S. in
biochemistry and molecular biology and B.A. in Spanish from Michigan State
University, M.P.H. in international health epidemiology from the University of
Michigan, and Ph.D. in epidemiology in 2013 from the University of Alabama at
Birmingham. Dr. Vogtmann’s research
focuses on the association between the human microbiome and cancer risk and the
evaluation of methods for collection, storage, and processing of samples and
data for study of the human microbiome.
